[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@sanofi](/creator/twitter/sanofi)
"The CHMP recommended the approval of our medicine for certain adults and adolescents in the EU with #ChronicSpontaneousUrticaria (CSU) potentially providing a new option for people with this debilitating skin disease. CC: @Regeneron"  
[X Link](https://x.com/sanofi/status/1969996081179263152) [@sanofi](/creator/x/sanofi) 2025-09-22T05:24Z 148.8K followers, 1463 engagements


"Data from our phase X head-to-head study in people with chronic rhinosinusitis with nasal polyps (#CRSwNP) and coexisting asthma has been published in @LancetRespirMed. Learn more about the findings. CC: @Regeneron"  
[X Link](https://x.com/sanofi/status/1972179469252038766) [@sanofi](/creator/x/sanofi) 2025-09-28T06:00Z 148.7K followers, 1542 engagements


"We have presented Phase X data at #ESMO25 supporting the potential of our investigational therapy for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Read more CC: @OranoMed @RadioMedix"  
[X Link](https://x.com/sanofi/status/1980222306065711164) [@sanofi](/creator/x/sanofi) 2025-10-20T10:39Z 148.7K followers, XXX engagements


"#NEWS: Results from a phase X study evaluating a new investigational therapy in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) demonstrated potential benefit in a rare and difficult-to-treat cancer. Click here for more information CC: @OranoMed"  
[X Link](https://x.com/sanofi/status/1975790409109721258) [@sanofi](/creator/x/sanofi) 2025-10-08T05:08Z 148.7K followers, 1535 engagements


"Our Modulus facilities were named as one of @TIME Magazine 2025 Best Inventions in Medical & Healthcare These next-generation sites in France and Singapore produce multiple vaccines and biologics simultaneously bringing life-changing treatments to patients faster than ever"  
[X Link](https://x.com/sanofi/status/1976300630164767103) [@sanofi](/creator/x/sanofi) 2025-10-09T14:56Z 148.7K followers, 2096 engagements


"#NEWS: The @EMA_News CHMP has recommended the approval of our new treatment for adults with immune thrombocytopenia (#ITP) reinforcing our commitment to advance scientific innovation that addresses unmet patient needs in #RareDiseases. Learn more"  
[X Link](https://x.com/sanofi/status/1979155328177704996) [@sanofi](/creator/x/sanofi) 2025-10-17T11:59Z 148.7K followers, XXX engagements


"#NEWS: The @US_FDA accepted the filing of our sBLA for recently diagnosed stage X #Type1Diabetes for expedited review through the FDA Commissioners National Priority Voucher (CNPV) pilot program. Learn more"  
[X Link](https://x.com/sanofi/status/1980242597198090492) [@sanofi](/creator/x/sanofi) 2025-10-20T12:00Z 148.7K followers, 1340 engagements


"Results from a phase X study evaluating an investigational treatment for alpha-1 antitrypsin deficiency (#AATD) achieved all primary and key secondary endpoints. Read our press release to learn more about our research on this #RareDisease"  
[X Link](https://x.com/sanofi/status/1980863163630600221) [@sanofi](/creator/x/sanofi) 2025-10-22T05:05Z 148.7K followers, 1055 engagements


"#NEWS: FLUNITY-HD study in @TheLancet assessed the effectiveness of our high-dose #influenza vaccine against hospitalizations in 65+ vs standard-dose. Learn more"  
[X Link](https://x.com/sanofi/status/1980138861973151851) [@sanofi](/creator/x/sanofi) 2025-10-20T05:07Z 148.7K followers, 3061 engagements


"Our Q3 2025 Results are now available. Read the press release. #SanofiResults $SAN $SNY"  
[X Link](https://x.com/sanofi/status/1981609099067261424) [@sanofi](/creator/x/sanofi) 2025-10-24T06:30Z 148.7K followers, XXX engagements